{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:19:29Z","timestamp":1777461569418,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["14-527"],"award-info":[{"award-number":["14-527"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Reduced renal clearance of uric acid is a major contributor to hyperuricemia. The aim of this study was to examine clinical and genetic variables associated with fractional excretion of uric acid (FEUA).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants (with and without gout) in the Genetics of Gout in Aotearoa study with available genotyping and FEUA data were included (<jats:italic>n<\/jats:italic>\u2009=\u20091713). Ten FEUA-associated loci detected within a genome-wide association study for serum urate in a European population were analysed. A polygenic score for FEUA was calculated in each ancestry group to model the cumulative effects of the genetic variants on FEUA. Associations between FEUA and both clinical variables and polygenic score were tested using linear regression models.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean (SD) FEUA was 5.13 (2.70) % in Eastern Polynesian participants, 4.70 (5.89) % in Western Polynesian participants, and 5.89 (2.73) % in New Zealand European participants. Although association with FEUA was observed for <jats:italic>SLC2A9<\/jats:italic> rs11942223 in New Zealand European participants (<jats:italic>P<\/jats:italic>\u2009=\u20092.39\u2009\u00d7\u200910<jats:sup>\u2212\u20098<\/jats:sup>), this association was not observed in Eastern or Western Polynesian participants. The polygenic score was positively associated with FEUA in all ancestry groups. In New Zealand European participants, body mass index, diuretic use, polygenic score, and male sex were associated with FEUA and explained 22% of FEUA variance in the regression model. In Eastern and Western Polynesian participants, the tested variables explained 10% and 4% of FEUA variance respectively.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Both clinical and genetic variables contribute to renal clearance of uric acid<jats:italic>. SLC2A9<\/jats:italic> exerts effects on FEUA variance in people of European ancestry, but not in those of Polynesian ancestry. There is a large unexplained variance in FEUA, particularly in people of Polynesian ancestry.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-019-2016-6","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T17:04:27Z","timestamp":1573578267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Population-specific factors associated with fractional excretion of uric acid"],"prefix":"10.1186","volume":"21","author":[{"given":"Ravi K.","family":"Narang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Phipps-Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"8","key":"2016_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/ard.2005.049023","volume":"65","author":"E Pascual","year":"2006","unstructured":"Pascual E, Perdiguero M. Gout, diuretics and the kidney. Ann Rheum Dis. 2006;65(8):981\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2016_CR2","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1186\/ar4020","volume":"14","author":"DRW Kannangara","year":"2012","unstructured":"Kannangara DRW, Ramasamy SN, Indraratna PL, Stocker SL, Graham GG, Jones G, et al. Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients. Arthritis Res Ther. 2012;14(4):R189.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"2016_CR3","first-page":"255","volume":"10","author":"S Yamashita","year":"1986","unstructured":"Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986;10(4):255\u201364.","journal-title":"Int J Obes"},{"issue":"2","key":"2016_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","volume":"50","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50(2):239\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"2016_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1080\/15257770.2011.616564","volume":"30","author":"P Jutabha","year":"2011","unstructured":"Jutabha P, Anzai N, Wempe MF, Wakui S, Endou H, Sakurai H. Apical voltage-driven urate efflux transporter Npt4 in renal proximal tubule. Nucleos Nucleot Nucl. 2011;30(12):1302\u201311.","journal-title":"Nucleos Nucleot Nucl"},{"issue":"3","key":"2016_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/ard.51.3.375","volume":"51","author":"BT Emmerson","year":"1992","unstructured":"Emmerson BT, Nagel SL, Duffy DL, Martin NG. Genetic-control of the renal clearance of urate - a study of twins. Ann Rheum Dis. 1992;51(3):375\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2016_CR7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0022-5347(06)00272-2","volume":"175","author":"M Monga","year":"2006","unstructured":"Monga M, Macias B, Groppo E, Hargens A. Genetic heritability of urinary stone risk in identical twins. J Urol. 2006;175(6):2125\u20138.","journal-title":"J Urol"},{"issue":"5","key":"2016_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/00365510902814646","volume":"69","author":"SE Nilsson","year":"2009","unstructured":"Nilsson SE, Read S, Berg S, Johansson B. Heritabilities for fifteen routine biochemical values: findings in 215 Swedish twin pairs 82 years of age or older. Scand J Clin Lab Invest. 2009;69(5):562\u20139.","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"2016_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A Kottgen","year":"2013","unstructured":"Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145\u201354.","journal-title":"Nat Genet"},{"issue":"6","key":"2016_CR10","doi-asserted-by":"publisher","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5(6):e1000504.","journal-title":"PLoS Genet"},{"issue":"6","key":"2016_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","volume":"3","author":"QO Yang","year":"2010","unstructured":"Yang QO, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ-Cardiovasc Gene. 2010;3(6):523\u201330.","journal-title":"Circ-Cardiovasc Gene"},{"issue":"1","key":"2016_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","volume":"75","author":"AJ Phipps-Green","year":"2016","unstructured":"Phipps-Green AJ, Merriman ME, Topless R, Altaf S, Montgomery GW, Franklin C, et al. Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann Rheum Dis. 2016;75(1):124\u201330.","journal-title":"Ann Rheum Dis"},{"issue":"9654","key":"2016_CR13","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WHL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953\u201361.","journal-title":"Lancet"},{"issue":"1485","key":"2016_CR14","first-page":"8","volume":"131","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Dowell T, Gerard C, Gow P, Jackson G, Shuker C, et al. Gout in Aotearoa New Zealand: the equity crisis continues in plain sight. N Z Med J. 2018;131(1485):8\u201312.","journal-title":"N Z Med J"},{"issue":"4","key":"2016_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/rheumatology\/23.4.276","volume":"23","author":"T Gibson","year":"1984","unstructured":"Gibson T, Waterworth R, Hatfield P, Robinson G, Bremner K. Hyperuricaemia, gout and kidney function in New Zealand Maori men. Br J Rheumatol. 1984;23(4):276\u201382.","journal-title":"Br J Rheumatol"},{"issue":"10","key":"2016_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/rheumatology\/33.10.932","volume":"33","author":"HA Simmonds","year":"1994","unstructured":"Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol. 1994;33(10):932\u20137.","journal-title":"Br J Rheumatol"},{"issue":"11","key":"2016_CR17","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1136\/annrheumdis-2012-202732","volume":"72","author":"N Dalbeth","year":"2013","unstructured":"Dalbeth N, House ME, Gamble GD, Horne A, Pool B, Purvis L, et al. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis. 2013;72(11):1868\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2016_CR18","doi-asserted-by":"publisher","first-page":"e000424","DOI":"10.1136\/rmdopen-2016-000424","volume":"3","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth N, Allan J, Gamble GD, Phipps-Green A, Flynn TJ, Mihov B, et al. Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study. Rmd Open. 2017;3(1):e000424.","journal-title":"Rmd Open"},{"issue":"3","key":"2016_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895\u2013900.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2016_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jbspin.2016.04.007","volume":"84","author":"S Liu","year":"2017","unstructured":"Liu S, Perez-Ruiz F, Miner JN. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid. Joint Bone Spine. 2017;84(2):183\u20138.","journal-title":"Joint Bone Spine"},{"key":"2016_CR21","unstructured":"Ministry of Health. 2017. HISO 10001:2017 Ethnicity Data Protocols. Wellington: Ministry of Health. https:\/\/www.health.govt.nz\/publication\/hiso-100012017-ethnicity-data-protocols."},{"issue":"10","key":"2016_CR22","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136\u201341.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2016_CR23","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/ard.2006.051649","volume":"65","author":"LR Harrold","year":"2006","unstructured":"Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, et al. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006;65(10):1368\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2016_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12891-017-1465-9","volume":"18","author":"LR Harrold","year":"2017","unstructured":"Harrold LR, Etzel CJ, Gibofsky A, Kremer JM, Pillinger MH, Saag KG, et al. Sex differences in gout characteristics: tailoring care for women and men. BMC Musculoskelet Disord. 2017;18(1):108.","journal-title":"BMC Musculoskelet Disord"},{"issue":"5851","key":"2016_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/bmj.1.5851.449","volume":"1","author":"A Nicholls","year":"1973","unstructured":"Nicholls A, Snaith ML, Scott JT. Effect of estrogen therapy on plasma and urinary levels of uric acid. Brit Med J. 1973;1(5851):449\u201351.","journal-title":"Brit Med J"},{"issue":"6","key":"2016_CR26","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1210\/jc.2007-2467","volume":"93","author":"R Yahyaoui","year":"2008","unstructured":"Yahyaoui R, Esteva I, Haro-Mora JJ, Almaraz MC, Morcillo S, Rojo-Martinez G, et al. Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab. 2008;93(6):2230\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2016_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"PJ Savage","year":"1998","unstructured":"Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the systolic hypertension in the elderly program. SHEP Cooperative Research Group. Arch Intern Med. 1998;158(7):741\u201351.","journal-title":"Arch Intern Med"},{"key":"2016_CR28","doi-asserted-by":"publisher","first-page":"d8190","DOI":"10.1136\/bmj.d8190","volume":"344","author":"HK Choi","year":"2012","unstructured":"Choi HK, Soriano LC, Zhang YQ, Rodriguez LAG. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. Brit Med J. 2012;344:d8190.","journal-title":"Brit Med J"},{"issue":"2","key":"2016_CR29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1681\/ASN.2006040415","volume":"18","author":"Y Hagos","year":"2007","unstructured":"Hagos Y, Stein D, Ugele B, Burckhardt G, Bahn A. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol. 2007;18(2):430\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2016_CR30","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/bjp.2008.343","volume":"155","author":"AAK El-Sheikh","year":"2008","unstructured":"El-Sheikh AAK, van den Heuvel JJMW, Koenderink JB, Russel FGM. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Brit J Pharmacol. 2008;155(7):1066\u201375.","journal-title":"Brit J Pharmacol"},{"issue":"3","key":"2016_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ki.1989.206","volume":"36","author":"AM Kahn","year":"1989","unstructured":"Kahn AM. Indirect coupling between sodium and urate transport in the proximal tubule. Kidney Int. 1989;36(3):378\u201384.","journal-title":"Kidney Int"},{"issue":"4","key":"2016_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1445-5994.1973.tb03115.x","volume":"3","author":"BT Emmerson","year":"1973","unstructured":"Emmerson BT. Alteration of urate metabolism by weight reduction. Aust NZ J Med. 1973;3(4):410\u20132.","journal-title":"Aust NZ J Med"},{"key":"2016_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13075-015-0781-4","volume":"17","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, Phipps-Green A, House ME, Gamble GD, Horne A, Stamp LK, et al. Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout. Arthritis Res Ther. 2015;17:263.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2016_CR34","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1371\/journal.pmed.0050197","volume":"5","author":"MJ Caulfield","year":"2008","unstructured":"Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, Doblado M, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med. 2008;5(10):1509\u201323.","journal-title":"PLoS Med"},{"issue":"11","key":"2016_CR35","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/art.24938","volume":"60","author":"JE Hollis-Moffatt","year":"2009","unstructured":"Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum. 2009;60(11):3485\u201392.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2016_CR36","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.40110","volume":"69","author":"C Tanner","year":"2017","unstructured":"Tanner C, Boocock J, Stahl EA, Dobbyn A, Mandal AK, Cadzow M, et al. Population-specific Resequencing associates the ATP-binding cassette subfamily C member 4 gene with gout in New Zealand Maori and Pacific men. Arthritis Rheum. 2017;69(7):1461\u20139.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2016_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/annrheumdis-2015-208111","volume":"75","author":"DR Kannangara","year":"2016","unstructured":"Kannangara DR, Phipps-Green AJ, Dalbeth N, Stamp LK, Williams KM, Graham GG, et al. Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Ann Rheum Dis. 2016;75(7):1363\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2016_CR38","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/db07-1807","volume":"57","author":"M Vaxillaire","year":"2008","unstructured":"Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, Balkau B, et al. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes. 2008;57(8):2253\u20137.","journal-title":"Diabetes"},{"issue":"2","key":"2016_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/hmg\/ddp489","volume":"19","author":"P van der Harst","year":"2010","unstructured":"van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, Caulfield MJ, et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet. 2010;19(2):387\u201395.","journal-title":"Hum Mol Genet"},{"key":"2016_CR40","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-018-06620-4","volume":"9","author":"A Tin","year":"2018","unstructured":"Tin A, Li Y, Brody JA, Nutile T, Chu AY, Huffman JE, et al. Large-scale whole-exome sequencing association studies identify rare functional variants influencing serum urate levels. Nat Commun. 2018;9:4228.","journal-title":"Nat Commun"},{"issue":"5","key":"2016_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.568","volume":"42","author":"A Kottgen","year":"2010","unstructured":"Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42(5):376\u201384.","journal-title":"Nat Genet"},{"key":"2016_CR42","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1038\/ncomms10023","volume":"7","author":"C Pattaro","year":"2016","unstructured":"Pattaro C, Teumer A, Gorski M, Chu AY, Li M, Mijatovic V, et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun. 2016;7:10023.","journal-title":"Nat Commun"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-2016-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:33:12Z","timestamp":1605054792000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-2016-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-2016-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The New Zealand Multi-Region Ethics Committee (MEC\/105\/10\/130) granted ethical approval for the study, and all participants gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca\/Ironwood, Kowa, Horizon, Amgen, Abbvie, Takeda, Pfizer and Janssen. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}